Trial ID or NCT#



recruiting iconRECRUITING


This study is to evaluate the pharmacokinetics, pharmacodynamics, and safety of single and multiple doses of armodafinil (50, 100, and 150 mg/day) in children and adolescents with excessive sleepiness associated with narcolepsy.

Official Title

A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

Eligibility Criteria

Ages Eligible for Study: 6 Years to 17 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Clete A. Kushida, MD, PhD
Clete A. Kushida, MD, PhD
Sleep specialist, Neurologist
Professor of Psychiatry and Behavioral Sciences

Contact us to find out if this trial is right for you.


Paul Stowers
(650) 721-7551